These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effect of platelet-derived growth factor and bone marrow-conditioned medium on the proliferation of human bone marrow-derived fibroblastoid colony-forming cells. Hirata J, Kaneko S, Nishimura J, Motomura S, Ibayashi H. Acta Haematol; 1985; 74(4):189-94. PubMed ID: 3939058 [Abstract] [Full Text] [Related]
23. The vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584 inhibits growth and migration of multiple myeloma cells in the bone marrow microenvironment. Lin B, Podar K, Gupta D, Tai YT, Li S, Weller E, Hideshima T, Lentzsch S, Davies F, Li C, Weisberg E, Schlossman RL, Richardson PG, Griffin JD, Wood J, Munshi NC, Anderson KC. Cancer Res; 2002 Sep 01; 62(17):5019-26. PubMed ID: 12208756 [Abstract] [Full Text] [Related]
27. Interleukin-1 beta, transforming growth factor beta 1, prostaglandin E2, and fibronectin levels in the conditioned mediums of bone marrow fibroblast cultures from lung and breast cancer patients. Honegger AE, Hofer EL, Barañao RI, Mackinlay TA, Mackinlay DA, Bullorsky EO, Bordenave RH, Chasseing NA. Ann Hematol; 2002 Feb 01; 81(2):80-5. PubMed ID: 11907787 [Abstract] [Full Text] [Related]
28. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma. Tassone P, Neri P, Burger R, Savino R, Shammas M, Catley L, Podar K, Chauhan D, Masciari S, Gozzini A, Tagliaferri P, Venuta S, Munshi NC, Anderson KC. Clin Cancer Res; 2005 Jun 01; 11(11):4251-8. PubMed ID: 15930364 [Abstract] [Full Text] [Related]
29. Differential regulation of cytokine and receptor transcript expression in human corneal and limbal fibroblasts by epidermal growth factor, transforming growth factor-alpha, platelet-derived growth factor B, and interleukin-1 beta. Li DQ, Tseng SC. Invest Ophthalmol Vis Sci; 1996 Sep 01; 37(10):2068-80. PubMed ID: 8814146 [Abstract] [Full Text] [Related]
30. In vitro functions of stromal cells from human and mouse bone marrow. Zipori D, Reichman N, Arcavi L, Shtalrid M, Berrebi A, Resnitzky P. Exp Hematol; 1985 Aug 01; 13(7):603-9. PubMed ID: 4029289 [Abstract] [Full Text] [Related]
31. Biological characterization of CD34+ cells mobilized into peripheral blood. Lemoli RM, Tafuri A, Fortuna A, Catani L, Rondelli D, Ratta M, Tura S. Bone Marrow Transplant; 1998 Dec 01; 22 Suppl 5():S47-50. PubMed ID: 9989890 [Abstract] [Full Text] [Related]
32. Fibroblast proliferation by bleomycin stimulated peripheral blood mononuclear cell factors. Yamamoto T, Katayama I, Nishioka K. J Rheumatol; 1999 Mar 01; 26(3):609-15. PubMed ID: 10090171 [Abstract] [Full Text] [Related]
33. In vitro activation of human fibroblasts by retrieved titanium alloy wear debris. Manlapaz M, Maloney WJ, Smith RL. J Orthop Res; 1996 May 01; 14(3):465-72. PubMed ID: 8676260 [Abstract] [Full Text] [Related]
34. New immortalized human stromal cell lines enhancing in vitro expansion of cord blood hematopoietic stem cells. De Angeli S, Di Liddo R, Buoro S, Toniolo L, Conconi MT, Belloni AS, Parnigotto PP, Nussdorfer GG. Int J Mol Med; 2004 Mar 01; 13(3):363-71. PubMed ID: 14767565 [Abstract] [Full Text] [Related]
35. Production of bone-resorbing activity and colony-stimulating activity in vivo and in vitro by a human squamous cell carcinoma associated with hypercalcemia and leukocytosis. Sato K, Mimura H, Han DC, Kakiuchi T, Ueyama Y, Ohkawa H, Okabe T, Kondo Y, Ohsawa N, Tsushima T. J Clin Invest; 1986 Jul 01; 78(1):145-54. PubMed ID: 3487554 [Abstract] [Full Text] [Related]